Resources

NEW YORK, April 15, 2020 – FRONTEO (TSE: 2158) Kyowa Pharmaceutical and FRONTEO have partnered to develop an AI-based dementia diagnosis support system, using FRONTEO’s proprietary natural language processing AI Concept Encoder.

The Dementia Diagnosis Support System (DDSS), powered by FRONTEO’s AI Concept Encoder...

NEW YORK, April 15, 2020 – FRONTEO (TSE: 2158) Kyowa Pharmaceutical and FRONTEO have partnered to develop an AI-based dementia diagnosis support system, using FRONTEO’s proprietary natural language processing AI Concept Encoder.

The Dementia Diagnosis Support System (DDSS), powered by FRONTEO’s AI Concept Encoder...

VDI solution by Google Cloud and FRONTEO’s AI Review “KIBIT Automator” will allow secure review platform access without compromising performance for attorneys working remotely.

NEW YORK, March 25, 2020 – FRONTEO (TSE: 2158), a leading eDiscovery services provider, has migrated its Managed Review Service serviced...

Proof of concept achieve 20% reduction in documents for review and an average review speed of 91.6 documents/hour, resulting in 28.6% cost savings.

NEW YORK, November 25 , 2019 – FRONTEO (NASDAQ: FTEO) (TSE: 2158), a leading eDiscovery services provider, announced today that it has worked with lawyers at...